2025 Clinic Diabetes Patient-Centered 
Physician's Weekly
JUNE 17, 2025
Postural sway velocity as a screening tool in diabetic peripheral neuropathy represents a potential early marker of balance impairment and fall risk. The 2025 annual meeting of the Peripheral Nerve Society (PNS) took place in Edinburgh, Scotland, from May 17, 2025 to May 20, 2025.
Permanente Medicine
JUNE 10, 2025
June 10, 2025) — Maria Ansari, MD, FACC , co-CEO of The Permanente Federation at Kaiser Permanente, has been named to Modern Healthcare’s list of 50 Most Influential Clinical Executives for 2025. The result is high-quality, high-value care within an integrated system — improving lives and shaping the future of health care.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Weekly
JUNE 17, 2025
The ADA’s 85th Scientific Sessions will highlight breakthroughs in obesity and diabetes care, including GLP-1 therapies, tech advances, and prevention tools. Per a press release by the ADA, attendees can expect to see clinical research showcasing the latest innovations in obesity care. Roughly 42% (109.9
Permanente Medicine
APRIL 16, 2025
Affiliation will allow groups to drive high-value care and innovation PORTLAND, ORE, April 16, 2025 – Oregon-based Northwest Permanente (NWP) and The Permanente Medical Group (TPMG) of Northern California announced a formal affiliation today. What is different and exciting about our affiliation is our shared belief in value-based care.
Physician's Weekly
JUNE 16, 2025
MONDAY, June 16, 2025 (HealthDay News) — Transfibular total ankle arthroplasty (TAA) seems effective and durable for end-stage ankle arthritis, according to a study published online April 29 in The Journal of Bone & Joint Surgery. years after primary TAA to examine implant survivorship and clinical and radiographic outcomes.
GeriPal
JANUARY 23, 2025
Today, we explore four fascinating studies highlighting innovative approaches to reducing medication use and improving patient outcomes. Patients received brochures detailing the risks of gabapentinoids, nonpharmacologic alternatives, and a proposed deprescribing regimen (see here for the brochure ).
GeriPal
JANUARY 16, 2025
So I think the first reason that we saw and felt the opportunity was ripe for updating was that some of us had come across some anecdotal examples of patients expressing some offense to that terminology. And I was asking this patient about if he had filled out an advanced directive. Is the patient in your descriptor?
Expert insights. Personalized for you.
52 
Let's personalize your content